Drug Type TCR therapy |
Synonyms |
Target |
Mechanism EBV Protein inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization SCG Cell Therapy Pte. Ltd.Startup |
Active Organization SCG Cell Therapy Pte. Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nasopharyngeal Carcinoma | Preclinical | SG | SCG Cell Therapy Pte. Ltd.Startup | 06 Jun 2023 |